Pfeiffenberger Brent 4
4 · Century Therapeutics, Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Pfeiffenberger Brent
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-03-07+17,425→ 1,470,704 total - Award
Stock Option (right to buy)
2024-03-07+104,550→ 104,550 totalExercise: $5.32Exp: 2034-03-07→ Common Stock (104,550 underlying)
Footnotes (3)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on March 7, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
- [F2]This Form 4 was originally filed under the incorrect Issuer on March 11, 2024 due to an administrative error (the "Original Form 4"). The Original Form 4 is being refiled to appear associated with the correct Issuer.
- [F3]The option vests 25% on March 7, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.